Rationale
The widespread use of percutaneous coronary interventions (percutaneous transluminal coronary angioplasty and/or stenting) (PCI) has resulted in a greater number of patients being referred for coronary artery bypass grafting (CABG) after prior PCI. Depending on the studies on bare metal stents, from 6 to 13% of patients undergo CABG within 1 year after PCI, and from 13 to 26% within 10 years. 1 -3 When a patient is eligible for both procedures, PCI is often preferred to surgery. 4 The initial choice of PCI is reinforced by the perception that patients can safely be referred to surgery after PCI. However, little is known about the outcomes in patients who develop recurrent symptoms after initial PCI necessitating subsequent revascularization by CABG. The objective of this study was to assess the association between prior PCI and patients' outcome after subsequent revascularization by CABG. In order to do this, we used the contemporary IMAGINE (Ischemia Management with Accupril post bypass Graft via Inhibition of the coNverting Enzyme) trial database of 2553 patients with preserved left ventricular function undergoing CABG. IMAGINE patients with redo CABG were excluded from this study.
Methods

IMAGINE study
The design of the IMAGINE study, previously described, 5 as well as the results of the main study, 6 is summarized here. The IMAGINE study is a double-blind, placebo-controlled, parallel group, randomized, multicentre international study conducted in patients who have undergone CABG between November 1999 and September 2004. Patients were screened for eligibility within 4 weeks of surgery or following surgery, and randomized within 7 days post-CABG, except for France where randomization occurred within 10 days post-CABG.
Endpoints
The primary endpoint was the time to first occurrence of any of the composite of cardiovascular death or resuscitated cardiac arrest, nonfatal myocardial infarction (MI), coronary revascularization, unstable angina requiring hospitalization, documented angina not requiring hospitalization, stroke, or congestive heart failure requiring hospitalization.
Patient characteristics
Of the 2553 patients who underwent randomization, 1280 were assigned to receive quinapril, and 1273 matching placebo. Baseline characteristics were similar in both treatment groups. The mean age was of 61 years; 13% were women, 10% had diabetes, 3% had previous CABG, and 18% had previous PCI. Left ventricular ejection fraction (LVEF) was 60%.
Follow-up and compliance
Median follow-up was of 2.95 years. A total of 330 patients experienced a primary endpoint. Among the patients who did not present a primary endpoint, 201 had a 12 month follow-up or less, 547 had more than 12 months but 24 months, 451 had more than 24 months but 36 months, and 1024 had more than 36 months. One patient on quinapril and four patients in placebo were lost to follow-up.
Primary endpoint
The incidence of the primary endpoint was 12.2% in the placebo group and 13.7% in the quinapril group (hazard ratio 1.15; 95% confidence intervals, 0.92 -1.42; P ¼ 0.212). Adjustment for baseline characteristics (age, sex, history of MI, stroke, diabetes, or previous CABG) did not alter the results. When individual components of the primary endpoint were considered separately, no differences in the primary endpoint according to treatment group were found.
The current study
We classified patients into two groups: those who had a history of percutaneous transluminal coronary angioplasty and/or stenting before surgery (PCI group) and those who were referred to surgery without any percutaneous transluminal coronary angioplasty and/or stenting in their history (non-PCI group).
Completeness of coronary revascularization
Myocardial revascularization completeness was evaluated by the two most common definitions. The first being all vessels .1 mm with a stenosis .70% having been bypassed (Definition 1), and the second is the presence of at least one graft on a coronary territory supplied by a vessel with !70% stenosis (Definition 2).
Endpoints
We used the same endpoints as the IMAGINE trial. The primary endpoint was the time to first occurrence of any of the composite events. Time-to-event data continued to be captured for individual component endpoints even after the first primary endpoint had been experienced. For individual endpoints, we calculated the time to the first occurrence regardless of whether it was the first event occurring in the patient.
Statistical analysis
Differences between the PCI group and the non-PCI group were estimated as a hazard ratio, including the associated adjusted two-sided 95% confidence interval from a Cox proportional hazards regression model that includes the effects of treatment group, LVEF, number of distal anastomosis, if all vessels .1 mm with a stenosis .70% were bypassed, the presence of at least one graft on a coronary territory supplied by a vessel with !70% stenosis, number of diseased vessels, if LM stenosis was .50%, hypertension, gender, previous MI, previous stroke, age, diabetes, and beating heart (off pump) surgery. Assumption of proportional hazard was assessed using log-negativelog plot and the interaction 'group Â time'. Additionally, the effects of these covariates were assessed in a univariate COX model. The Efron method was used for handling event ties.
Categorical variables are described as percentages, and either the x 2 test or Fisher exact test was used depending on the size of each cell. Continuous variables are expressed as the mean value + SD if normally distributed or the median value (interquartile range) if the distribution was skewed. The differences were tested by t-test or Wilcoxon rank sum test when appropriate. The hazard ratio and 95% confidence intervals were used to compare the delay between PCI and randomization, 6 to .6 months.
In an additional effort to control for systematic differences between the PCI and non-PCI groups, we applied the propensity score stratification technique. 7 A stepwise logistic regression model was used to estimate propensity scores based on baseline and operative variables mentioned above. For continuous variables, we compared the groups after adjusting for their propensity quintile using a two-way analysis of variance model that included the main effects for propensity score quintile and group and the two-way interaction of quintile and group. For two-level categorical variables, we determined the significance level of the Breslow-Day test of the homogeneity of the quintilespecific odds ratio (OR) and the Mantel -Haenszel test of the significance of the common OR. For categorical variables with more than two levels of responses, logistic regression was used to assess comparability. The model included propensity score quintile and group as independent variables as well as the two-way interaction of quintile and group. Hazard ratios from a Cox proportional hazards regression model were then calculated by incorporating the group and the propensity score quintile into the model.
Results
Patient characteristics
Of the 2553 patients included in the IMAGINE trial, 455 (17.8%) had a history of PCI prior to surgery (PCI group) and 2098 (82.2%) were referred to surgery without previous PCI (non-PCI group). After the exclusion of patients with previous CABG, 430 (17.3%) and 2059 (82.7%) patients are in the PCI and non-PCI groups, respectively. Baseline characteristics are given in Table 1 .
Proportion of patients assigned in the quinapril arm was 49.1% in the PCI group and 50.1% in the non-PCI group, P ¼ 0. Total cholesterol, LDL-C, and HDL-C were better controlled in the PCI group ( Table 1) . LVEF was equivalent in both groups. The medical therapy of patients in both groups was similar.
Characteristics of the CABG
The distribution of patients with one-, two-, or three-vessel disease was unbalanced with remarkably more patients with onevessel disease in the PCI group (12.3 vs. 6.6%) ( Table 2 ). The number of patients with left main coronary artery (LM) stenosis is lower in the PCI group. The average number of distal anastomosis was significantly lower in the PCI group; however, completeness of coronary revascularization appeared to be equivalent between groups, with Definition 1 favouring more complete revascularization in PCI group, and Definition 2 favouring more complete revascularization in the non-PCI group. The ratio number of saphenous vein anastomosis by the total number of anastomosis was significantly lower in the PCI group [0.43 (0.31)] than in the non PCI group [0.48 (0.29), P ¼ 0.003], suggesting that more arterial anastomosis was performed in PCI patients. The number of off-pump procedures performed was equivalent in both groups.
Comparability after adjusting for the propensity score quintile For continuous variables, the results from the two-way analysis for the patient and CABG characteristics revealed that balance was achieved after stratification based on the propensity score. The two-way interaction of quintile and group was non-significant in all instances. For categorical variables with two-level responses, the Breslow-Day test of the homogeneity of the quintile-specific OR was non-significant in all instances except for the covariate previous MI. The x 2 test was significant for the second quintile Hazard ratios are adjusted for ejection fraction, no. of distal anastomosis, all vessels .1 mm with a stenosis .70% have been bypassed, the presence of at least one graft on a coronary territory supplied by a vessel with !70% stenosis, no. of diseased vessels, if LM stenosis is !50%, hypertension, gender, MI, stroke, age, diabetes, treatment and beating heart.
1.68[1.14-2.46], P ¼ 0.0081. Adjusting for baseline characteristics, the hazard ratio was 1.59[1.08 -2.34], P ¼ 0.0190. Our data met the assumption of proportional hazards as the effect of the predictor variable does not change across time (P ¼ 0.99).
Discussion
Among the 2553 patients included in the IMAGINE study, 64 had a previous CABG. Because this specific population (i) had specific needs in terms of coronary revascularization which was different from the overall population, (ii) raised specific questions in terms of PCI (native vessel or graft stenoses), and (iii) was unbalanced between the two groups [25 (5.5%) in the PCI group and 39 (1.9%) in the non-PCI group, p , 0.0001], we excluded these patients from the current analysis.
This analysis of the IMAGINE study database indicates that patients with preserved systolic function having had a previous PCI had a worse outcome post-CABG (unadjusted HR for IMAGINE primary endpoint ¼ 1.53 [1.17-1.98]), even after adjusting for baseline cardiovascular risk factors and propensity score quintile. This increased risk was particularly marked for unstable angina requiring hospitalization (HR ¼ 2.43 [1.52-3.89]) and coronary revascularization (HR ¼ 1.80 [1.13-2.87]).
Previous studies showed diabetes, 8 number of diseased vessels, 8 type of lesion, 9 topography of the lesions, 9 and incomplete PCI revascularization 9,10 as risk factors for requiring a subsequent CABG after PCI.
Other studies showed the increased risk of PCI patients when undergoing CABG.
W Using multivariate and propensity score matching techniques in 6032 patients presenting for CABG, Hassan et al. 11 found that patients with prior PCI had greater in-hospital mortality (OR ¼ 1.93, P ¼ 0.003) despite less co-morbidity and, as found in IMAGINE, less coronary artery disease. Patients with prior PCI did, however, have more advanced symptoms and greater urgency for CABG. As in the IMAGINE study, randomization was done after CABG, intra-operative mortality was not available.
W Kalaycioglu et al. 12 compared, with a 36 month follow-up, 40
patients who had undergone CABG with a prior PCI with a case-matched control group of 40 patients who underwent CABG without prior PCI. As in our study, patients with a prior PCI had less extensive coronary artery disease, and requiring fewer bypass grafts had a greater risk of angina and need for repeat revascularization. The worse surgical results in PCI patients could be explained by a more serious disease in PCI patients. This hypothesis is not supported by our data:
W PCI patients have, not at the time of operation, a more advanced coronary artery disease.
W In the PCI group, there were more patients with one-or twovessel disease and less patients with three-vessel disease or LM disease than in the non-PCI.
W If patients with a previous PCI had more often a history of MI than non-PCI patients, their ejection fraction remains equivalent to that of non-PCI patients.
W PCI patients were better treated than non-PCI patients.
W Although patients in the PCI group had more statin and acetylsalicyclic acid (ASA) use pre-CABG, there was no difference in the therapy between groups during the postoperative study period ( Table 5) .
W The ratio number of saphenous vein anastomosis to the total number of anastomoses was significantly lower in the PCI group than in the non-PCI group, showing that more arterial anastomosis (with a better theoretical patency) were performed in PCI patients.
W The discrepancy between the results of the two definitions for completeness of revascularization between groups suggests that there were more patients with poor vessel runoff in the non-PCI group.
W There were less coronary artery grafts per patient in the PCI group, but with a more complete surgical revascularization. 
Limitations
Limitations of the study include the fact that this is an analysis of the IMAGINE trial and, hence, was not designed specifically to determine the impact of PCI on outcome of CABG. Owing to the inclusion period of the IMAGINE study and of most of the referenced studies, our conclusions are not relevant for drug-eluting stents.
Conclusions
Our study shows that patients with an LVEF of !40% having a history of PCI have a worse prognosis post-CABG. Although this association may simply be a reflection of more aggressive coronary artery disease in these patients, the hypothesis that PCI has a negative effect per se cannot be excluded. Therefore, the current practice favouring PCI to CABG when a patient is eligible for both procedures and has a high likehood of requiring a subsequent CABG has to be revisited, because previous PCI may alter the outcomes post-CABG. 'If PCI does not work, the patient will be referred safely to surgery' is no longer a valid assumption and warrants confirmation by a randomized, controlled trial. 
